Apotex recalls Fluticasone Propionate Nasal Spray 50mcg 120 sprays due to potential Burkholderia cepacia contamination. This may pose health risks for users with compromised immune systems.
“Apotex Fluticasone Nasal Spray Recall: Potential Burkholderia cepacia Contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32826-apotex-fluticasone-nasal-spray-recall-potential-burkholderia-cepacia-contamination. Based on FDA recall #D-0326-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0326-2024%22&limit=1).
The FDA announced on Feb. 9, 2024, that Apotex Corp. is voluntarily recalling Fluticasone Propionate Nasal Spray USP 50mcg due to potential presence of Burkholderia cepacia complex from CGMP deviations. The agency issued recall number D-0326-2024 for the Class II recall.
How to tell if you have it
Brand: Apotex
Product: Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill
NDC: 60505-0829-1
Lot number: TX5274
Expiration date: 09/30/2026
Quantity: 292,752 bottles
The hazard
The recall addresses CGMP deviations that may result in the potential presence of Burkholderia cepacia complex in the product. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Apotex Corp. has 24 other recalls on record since 2007-06-14. Recent Apotex actions include a Sept. 23, 2026, recall of Paroxetine 37.5mg due to dissolution failure and an Aug. 13, 2026, recall of Paxil CR 37.5mg Tablets for failed stability testing. Other recent recalls of similar products include Walgreens Saline Nasal Spray with Xylitol Recall (Nov. 12, 2025), ClearLife Allergy Nasal Spray Recall (Dec. 12, 2025), and Medinatura ReBoost Nasal Spray Recall (Dec. 12, 2025).
How to tell if you have this one
Check for the product name 'Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays' with lot number #TX5274 and expiration date 09/30/2026. The product is manufactured by Apotex Inc. in Toronto, Ontario, Canada.
Brand
Apotex
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the lot number and expiration date on the product label to confirm if it matches #TX5274 expiring 09/30/2026.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The recall is for potential bacterial contamination, which could cause infections in vulnerable individuals. There is no mention of immediate physical injury risks in normal use.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0326-2024 (February 9, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0326-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.